ALT
|
alternative lengthening of telomeres
|
APL |
acute promyelocytic leukemia |
B-NHEJ |
backup non-homologous end-joining |
BER |
base excision repair |
BIR |
break-induced replication |
BRCA1/2 HR |
BRCA1/2-mediated homologous recombination |
CML |
chronic myeloid leukemia |
CPC |
cancer progenitor cell |
D-NHEJ |
DNA-PK-mediated non-homologous end-joining |
DDR |
DNA damage response |
D-Loop |
displacement loop |
DSB |
DNA double strand break |
EOC |
epithelial ovarian cancer |
HR |
homologous recombination |
MMEJ |
microhomology-mediated end-joining |
NHEJ |
non-homologous end-joining |
PARP1i |
poly(ADP-ribose) polymerase 1 inhibitor |
RAD52 HR |
RAD52-mediated homologous recombination |
RAD52i |
RAD52 inhibitor |
SSA |
single strand annealing |
SSB |
DNA single strand break |
ssDNA |
single stranded DNA |
TA-HR |
transcription-associated homologous recombination |
TC-HR |
transcription-coupled homologous recombination |
TNBC |
triple negative breast cancer |